ProBio

ProBio provides end-to-end CDMO service from drug discovery to commercialization

[ProBio @ProBioCDMO]

Find us at Booth 107 at American Society of Hematology meeting! Transform patients' lives with GenScript ProBio's help. Let us show you how we can make a difference for your project. #ash22 #myeloma #ash2022 #hematology

[ProBio @ProBioCDMO]

Recently, Selecxine, a partner of GenScript ProBio, announced MFDS clearance of its phase I/II clinical trial application for innovative antibody drug program (SLC-3010). This is the second IND clearance of Selecxine followed by their earlier approval from the USFDA in July 2022.

[ProBio @ProBioCDMO]

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

Learn more via https://t.co/gOTBI9XrIK

[ProBio @ProBioCDMO]

Join us for a 60 minutes webinar to know more about bi-specific antibody CMC strategies including cell line development, upstream process development, downstream process development, and analytical method development.

Register here: https://t.co/7Man6ntBTt

[ProBio @ProBioCDMO]

Join this #webinar to learn more about the development of an exciting new #radioimmunotherapy and #IND-enabling #CMC Strategies for #mAb and #bsAb

https://t.co/RAELw1NuZh

[ProBio @ProBioCDMO]

Buchang Biopharmaceutical and REMD Biotherapeutics, partners of GenScript ProBio, recently received #IND approval of BC008-1A from China #NMPA for Phase 1 clinical trial. BC008-1A (NMPAIND number: CXSL2200315),for treatment of patients with advanced solid tumors.

[ProBio @ProBioCDMO]

GenScript ProBio, a leading Biologics #CDMO to the bio-pharmaceutical market, and #mAbsolve, developers of a novel Fc silencing variant, announced a licensing deal for mAbsolve’s Fc silencing technology.

[ProBio @ProBioCDMO]

Are you puzzled about the analytical control strategy for different plasmid DNA product applications? If so, don’t hesitate, come and join us for the upcoming webinar!

Wednesday | November 30th, 2022 | 3:00PM GMT

Register now to reserve your seat: https://t.co/PH30H8IUOb

[ProBio @ProBioCDMO]

#Radioimmunotherapy (RIT) is an emerging approach for the diagnosis, therapy, and monitoring of solid #tumors. It is a great honor to invite Dr Brad Walsh, CEO of #Glytherix, to share a topic on the development of exciting new radioimmunotherapy for #cancer patients.

[ProBio @ProBioCDMO]

👋 The production of #plasmid DNA is a critical component of the development of many advanced cell therapy and gene therapy procedures, such as viral vectors and vaccines. Discover how our experts can help you on your therapeutic project. Learn more: https://t.co/iRewvufDHK

[ProBio @ProBioCDMO]

Our industry is under pressure to increase productivity and reduce costs. Get in touch with our expert to learn how our flexible and intensified manufacturing solutions can help you reduce your product's cost. Join our webinar: https://t.co/XdKjQaLsyw

[ProBio @ProBioCDMO]

Leverage our deep technical collaborative approach to bring you biologic successfully to clinical trial and the market. Schedule a meeting with Lingqi Kong at the Antibody Society Meeting! #development #manufacturing
#antibodydiscovery #antibodytherapeutics #cartcelltherapy

[ProBio @ProBioCDMO]

👋 The production of #plasmid DNA is a critical component of the development of many advanced cell therapy and gene therapy procedures, such as viral vectors and vaccines. Discover how our experts can help you on your therapeutic project. Learn more: https://t.co/iRewvufDHK

[ProBio @ProBioCDMO]

Leverage our deep technical collaborative approach to bring you biologic successfully to clinical trial and the market. Schedule a meeting with Lingqi Kong at the Antibody Society Meeting! #development #manufacturing
#antibodydiscovery #antibodytherapeutics #cartcelltherapy

[ProBio @ProBioCDMO]

Our industry is under pressure to increase productivity and reduce costs. Get in touch with our expert to learn how our flexible and intensified manufacturing solutions can help you reduce your product's cost. Join our webinar: https://t.co/XdKjQaLsyw

[ProBio @ProBioCDMO]

In this #webinar, you will learn:
• DNA based #vaccine/drug MKT trend
• #Plasmid development and manufacturing strategy
• Plasmid platform in GenScript ProBio: 20 #IND approvals in CN, AP, EU and US

Registration Link: https://t.co/3OG2qD2pWi

[ProBio @ProBioCDMO]

Leverage our deep technical collaborative approach to bring you biologic successfully to clinical trial and the market. Schedule a meeting with Lingqi Kong at the Antibody Society Meeting! #development #manufacturing
#antibodydiscovery #antibodytherapeutics #cartcelltherapy

[ProBio @ProBioCDMO]

Leverage our deep technical collaborative approach to bring you biologic successfully to clinical trial and the market. Schedule a meeting with Lingqi Kong at the Antibody Society Meeting! #development #manufacturing
#antibodydiscovery #antibodytherapeutics #cartcelltherapy

[ProBio @ProBioCDMO]

👋 The production of #plasmid DNA is a critical component of the development of many advanced cell therapy and gene therapy procedures, such as viral vectors and vaccines. Discover how our experts can help you on your therapeutic project. Learn more: https://t.co/iRewvtY2ja

[ProBio @ProBioCDMO]

Our industry is under pressure to increase productivity and reduce costs. Get in touch with our expert to learn how our flexible and intensified manufacturing solutions can help you reduce your product's cost. Join our webinar: https://t.co/XdKjQaM0o4